Login / Signup

Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia.

Vanessa E KennedyGavin HuiTali AzenkotDaria GautMatthew J WieduwiltCaspian OliaiBrian A JonasVarun MittalAaron C LoganLori S MufflyGabriel N Mannis
Published in: American journal of hematology (2022)
Keyphrases
  • stem cell transplantation
  • bone marrow
  • chronic lymphocytic leukemia
  • cell therapy
  • high dose
  • type diabetes
  • stem cells
  • mesenchymal stem cells
  • weight loss